Correlation Between Spyre Therapeutics and Valneva SE

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Valneva SE ADR, you can compare the effects of market volatilities on Spyre Therapeutics and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Valneva SE.

Diversification Opportunities for Spyre Therapeutics and Valneva SE

-0.53

Correlation Coefficient

Spyre Therapeutics  Valneva SE

Excellent diversification

The 3 months correlation between Spyre and Valneva is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Valneva SE go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Valneva SE

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Valneva SE. But the stock apears to be less risky and, when comparing its historical volatility, Spyre Therapeutics is 1.39 times less risky than Valneva SE. The stock trades about -0.08 of its potential returns per unit of risk. The Valneva SE ADR is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  432.00  in Valneva SE ADR on December 28, 2024 and sell it today you would earn a total of  294.00  from holding Valneva SE ADR or generate 68.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Valneva SE ADR

Spyre Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Valneva SE ADR

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Valneva SE ADR are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Valneva SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spyre Therapeutics and Valneva SE

The main advantage of trading using opposite Spyre Therapeutics and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.

The idea behind Spyre Therapeutics and Valneva SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.